{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:36:12Z","timestamp":1787502972459,"version":"build-2736575974"},"reference-count":48,"publisher":"BMJ","issue":"5","funder":[{"name":"This study was partly funded by the University of Toronto and University Health Network Chair in Neuromodulation to AF","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2024,10,24]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Deep brain stimulation (DBS) and infusion therapies are effective treatments for the motor complications of Parkinson\u2019s disease (PD), but less established is their role in fall prevention. This systematic review and network meta-analysis (NMA) aimed to evaluate the risk of falls associated with advanced therapies in PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Following PRISMA-NMA (Preferred Reporting Items for Systematic Reviews and Meta\u2010Analyses for Network Meta-analyses) guidelines, we searched PubMed, Medline, Embase and CINAHL up to 20 March 2024. Eligibility criteria based on PICOS (Population Intervention Control Outcome Study design) framework were used for DBS of the subthalamic nucleus (STN) or globus pallidus pars interna (GPi), or infusion therapies, compared with best medical treatment (BMT) or sham stimulation. Pairwise meta-analysis was conducted using RevMan V.5.4, and NMA using the netmeta package in R software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fourteen studies were included. A higher number of falls were observed in the DBS group compared with BMT, although the difference was not significant. Sensitivity analysis excluding a heterogeneity-contributing study showed a significantly higher fall risk in the DBS group (Risk Ratio (RR)=2.74, 95%\u2009CI 1.60, 4.67, p=0.0002). Subgroup analyses indicated that levodopa-carbidopa intestinal gel tended towards increased fall risk, while continuous subcutaneous infusion of (fos)levodopa (CSCI) significantly decreased risk with high certainty of evidence. NMA showed CSCI as the most effective in reducing falls, while STN DBS was associated with the highest risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>DBS, especially targeting the STN, may increase fall risk compared with other advanced non-DBS procedures. While LCIG might not alter fall risk, preliminary evidence suggests that CSCI positively affects fall prevention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42023420637.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2024-334521","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T13:25:20Z","timestamp":1732195520000},"page":"470-479","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Risk of fall with device-based advanced treatments in Parkinson\u2019s disease: a systematic review and network meta-analysis"],"prefix":"10.1136","volume":"96","clinical-trial-number":[{"clinical-trial-number":"nct05402163","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Rajasumi","family":"Rajalingam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Sorrento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5346-0180","authenticated-orcid":false,"given":"Alfonso","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"2025041009251776000_96.5.470.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00030-2"},{"key":"2025041009251776000_96.5.470.2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.131045"},{"key":"2025041009251776000_96.5.470.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70068-7"},{"key":"2025041009251776000_96.5.470.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2648.2010.05459.x"},{"key":"2025041009251776000_96.5.470.5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.11.2297"},{"key":"2025041009251776000_96.5.470.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct1208070"},{"key":"2025041009251776000_96.5.470.7","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70264-8"},{"key":"2025041009251776000_96.5.470.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70291-6"},{"key":"2025041009251776000_96.5.470.9","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-022-00963-9"},{"key":"2025041009251776000_96.5.470.10","doi-asserted-by":"crossref","DOI":"10.1177\/17562864221108018","article-title":"Levodopa-entacapone-carbidopa intestinal gel infusion in advanced Parkinson\u2019s disease: real-world experience and practical guidance","volume":"15","author":"Nyholm","year":"2022","journal-title":"Ther Adv Neurol Disord"},{"key":"2025041009251776000_96.5.470.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00400-8"},{"key":"2025041009251776000_96.5.470.12","first-page":"107","article-title":"Deep brain stimulation for the treatment of Parkinson\u2019s disease: efficacy and safety","volume":"2012","author":"Pouratian","year":"2012","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"2025041009251776000_96.5.470.13","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0265-3"},{"key":"2025041009251776000_96.5.470.14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.929"},{"key":"2025041009251776000_96.5.470.15","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27195"},{"key":"2025041009251776000_96.5.470.16","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385"},{"key":"2025041009251776000_96.5.470.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060281"},{"key":"2025041009251776000_96.5.470.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205158"},{"key":"2025041009251776000_96.5.470.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70093-4"},{"key":"2025041009251776000_96.5.470.20","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70308-8"},{"key":"2025041009251776000_96.5.470.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30108-3"},{"key":"2025041009251776000_96.5.470.22","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199912000-00024"},{"key":"2025041009251776000_96.5.470.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907083"},{"key":"2025041009251776000_96.5.470.24","article-title":"Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson\u2019s Disease: INSIGHTS Study","volume":"2022","author":"Chung","year":"2022","journal-title":"Parkinsons Dis"},{"key":"2025041009251776000_96.5.470.25","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28703"},{"key":"2025041009251776000_96.5.470.26","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000149637.70961.4C"},{"key":"2025041009251776000_96.5.470.27","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70293-X"},{"key":"2025041009251776000_96.5.470.28","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00052-8"},{"key":"2025041009251776000_96.5.470.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurom.2022.10.051"},{"key":"2025041009251776000_96.5.470.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09482-y"},{"key":"2025041009251776000_96.5.470.31","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh571"},{"key":"2025041009251776000_96.5.470.32","first-page":"355","article-title":"Comparison of Subthalamic Nucleus vs. Globus Pallidus Interna Deep Brain Stimulation in Terms of Gait and Balance; A Two Year Follow-Up Study","volume":"29","author":"Celiker","year":"2019","journal-title":"Turk Neurosurg"},{"key":"2025041009251776000_96.5.470.33","doi-asserted-by":"publisher","DOI":"10.1152\/jn.01052.2014"},{"key":"2025041009251776000_96.5.470.34","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25831"},{"key":"2025041009251776000_96.5.470.35","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2016.22"},{"key":"2025041009251776000_96.5.470.36","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq221"},{"key":"2025041009251776000_96.5.470.37","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00041-1"},{"key":"2025041009251776000_96.5.470.38","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.13445"},{"key":"2025041009251776000_96.5.470.39","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00659","article-title":"New Onset On-Medication Freezing of Gait After STN-DBS in Parkinson\u2019s Disease","volume":"10","author":"Mei","year":"2019","journal-title":"Front Neurol"},{"key":"2025041009251776000_96.5.470.40","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28021"},{"key":"2025041009251776000_96.5.470.41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ensci.2021.100387","article-title":"Levodopa-carbidopa intestinal gel therapy may cause \u201cSupra-ON freezing of gate\u201d in patients with Parkinson\u2019s disease with diphasic dyskinesia","volume":"25","author":"Oshiro","year":"2021","journal-title":"eNeurologicalSci"},{"key":"2025041009251776000_96.5.470.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2019.11.008"},{"key":"2025041009251776000_96.5.470.43","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-202285"},{"key":"2025041009251776000_96.5.470.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2014.12.019"},{"key":"2025041009251776000_96.5.470.45","doi-asserted-by":"publisher","DOI":"10.1038\/npjparkd.2015.11"},{"key":"2025041009251776000_96.5.470.46","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2021.78"},{"key":"2025041009251776000_96.5.470.47","doi-asserted-by":"publisher","DOI":"10.1590\/1980-5764-dn-2021-0019"},{"key":"2025041009251776000_96.5.470.48","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00533-1"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2024-334521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T12:25:24Z","timestamp":1744287924000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2024-334521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,4,10]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/jnnp-2024-334521"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2024-334521","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]}}}